Avita Medical has gained popularity by developing a medical device called "Spray-on-skin" which helps in treating burns on the skin.
The device was first developed by an Australian doctor Fiona Wood and it was used to help people injured in the 2005 Bali bombings. The company has taken a step further to make it commercial as ReCell and has started discussions with the FDA to make it available in the US market by 2017.
The US regulator has now given the company permission to apply for early regulatory approval for its spray-on skin technology. The ruling falls under new FDA guidelines, which are aimed at helping patients get more timely access to lifesaving medical devices.
"We are excited that we can now advance discussions with the agency to determine exactly how this changes our time frames," he added.